Latest Insider Transactions at Avita Medical, Inc. (RCEL)
This section provides a real-time view of insider transactions for Avita Medical, Inc. (RCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AVITA Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AVITA Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 22
2021
|
Jeremy Curnock Cook |
BUY
Grant, award, or other acquisition
|
Direct |
4,350
+50.0%
|
-
|
Dec 22
2021
|
Michael S Perry Director |
BUY
Grant, award, or other acquisition
|
Direct |
71,440
+7.9%
|
-
|
Dec 22
2021
|
Louis Drapeau Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,350
+48.12%
|
-
|
Dec 22
2021
|
Suzanne Crowe |
BUY
Grant, award, or other acquisition
|
Direct |
4,350
+33.95%
|
-
|
Dec 22
2021
|
Lou Panaccio |
BUY
Grant, award, or other acquisition
|
Direct |
4,350
+19.09%
|
-
|
Sep 20
2021
|
Suzanne Crowe |
BUY
Open market or private purchase
|
Direct |
1,066
+20.59%
|
$18,122
$17.08 P/Share
|
Sep 01
2021
|
Michael S Perry Director |
SELL
Open market or private sale
|
Direct |
11,220
-4.51%
|
$224,400
$20.68 P/Share
|
Sep 01
2021
|
Michael S Perry Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,754
+8.71%
|
-
|
Jul 06
2021
|
Michael Holder Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
Jul 06
2021
|
Kathy M. Mc Gee Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
Jul 06
2021
|
Erin Liberto Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
Jul 06
2021
|
Andrew Quick Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+50.0%
|
-
|
Jul 06
2021
|
Donna Shiroma General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+46.67%
|
-
|
Jun 02
2021
|
Michael S Perry Director |
SELL
Open market or private sale
|
Direct |
23,000
-9.27%
|
$391,000
$17.33 P/Share
|
Nov 17
2020
|
Sean Ekins Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|